Transcription
2011 Cancer Committee Annual ReportShands at the University of Floridawith statistical data from 2010
Message from the Shands at UF Cancer Committee ChairThis report represents my final duty as out-going chair of the Shands at UF Cancer Committee. I am proud of the committee’s recent accomplishments aimed atguiding and improving cancer care at Shands at the University of Florida, and I’mpleased to have had the opportunity to work with such dedicated physicians, nursesand support personnal who are deeply committed the care and treatment of patients.This committee provides the interdisciplinary groups involved in patient-centeredpatient care the opportunity to interact, collaborate, and coordinate efforts to establish and maintain the highest quality of service to our cancer patients and their families. Meeting quarterly, thecommittee’s goals continue to be that of auditing patient care, assuring the breadth and depth of educationalprograms, tumor conferences and other clinical activites, ensuring patient access to consultative services in alldisciplines and providing oversight and quality control of data from the Oncology Data Center.Our work is part of the UF Shands Cancer Center’s interdisciplinary initiative at the UF Health Science Center’sGainesville and Jacksonville campuses, Shands at UF in Gainesville, and Shands Jacksonville. More than 250clinicians and scientists perform original scientific discovery to enhance the diagnosis, treatment and prevention of cancer. This report demonstrates the clinical and research effort involved in that enterprise during thecalendar year 2011.Steven Hochwald, M.D.Associate Professor, SurgerySection Chief, Surgical OncologyChair, Shands at UF Cancer CommitteeCancer Care Summary: 2010 DataShands at the University of Florida Oncology Data Center has analyzed data for all patients with reportable disease first seen at UFShands Cancer Center between Jan. 1, 2010 and Dec. 31, 2010. During that time, 2,731 new cases were diagnosed and/or treated hereas either inpatients, outpatients, or both. Of these cases, 2,251 were analytic (82 percent) meaning they received all or part of their firstcourse of treatment at our facility. The remaining 480 (18 percent) were non-analytic, meaning patients were diagnosed and receivedtheir entire initial course of therapy elsewhere. The total new cases volume decreased by 6 percent from 2009, and decreased 3 percentfor analytic cases only. However, increases were noted in several overall and analytic site groups. Among them is colorectal with anincrease of 17 percent in total malignant cases. Kidney/renal cancers also experienced an increase of 14 percent over 2009 figures formalignant sites, and 8 percent for analytic cases. Prostate also experienced an increase of 44 percent over 2009 figures.Increases were seen in numerous sites. Primary sites with the greatest increases in total new case volumes overall were liver (24 percent), Hodgkin’s disease (20 percent), non-Hodgkin’s (15 percent), oral cavity (15 percent), and breast (4 eprcent). Several primary sitesexperienced declines in total new case volumes. These included prostate (44 percent decline), ovary (30 percent decline), kidney/renal(13 percent decline), and lung (8 percent decline).Holding to our customary patterns, individuals from virtually every county in the State of Florida continue to seek care at the UFShands Cancer Center. Individuals residing in counties of the North Central Florida and North East Florida areas comprised 53 percent (1,450) of the total new cases in 2010. This is only six cases fewer than the total new cases from the same geographic area in 2009.Figures from the top five individual counties in Florida are as follows: Alachua 565 (21 percent), Marion 288 (11 percent), Columbia107 (4 percent), Lake 107 (4 percent), and Citrus 94 (3 percent). Out of state cases accounted for 5 percent (146) of all new cases in2010.Cases for females totaled 1,293, or 47 percent. Cases for males totaled 1,438, or 53 percent. The female group decreased by 3 percentand males decreased by 9 percent.
New Cancer CasesPRIMARY SITEUNITED STATES1Breast ngProstateColorectalBladderNon-Hodgkin LymphomaCorpus UteriMelanomaLeukemiaCervixAll OthersTotal CasesSHANDS AT %1. These estimates are offered as a rough guide. They are calculated according to the distribution of estimated new cancer cases by state for the year2011. These figures were obtained from the 2011 Cancer Facts & Figures, published by the American Cancer Society. Excludes basal and squamous cellskin cancers and in-situ carcinomas (except urinary bladder).2. Shands at UF figures were obtained from the total number of accessioned cases at Shands at UF during 2010.Top Sites: Reportable, Analytic Cases (AJCC/TNM Staging)BREASTBRAIN/CNSLUNGORAL 84120107782522232023187800221134229
Ten Most Frequent Malignant SitesBreast 9.1%Site CountBREAST 226LUNG/BRONCHUS 212ORAL CAVITY 135KIDNEY/RENAL 140NON-HODGKIN’S LYMPHOMA128LIVER 126BLADDER 123MELANOMA 122COLORECTAL 121LEUKEMIA 99ALL OTHER SITES1063TOTAL2495Lung/Bronchus 8.5%Oral Cavity 5.4%All Other Sites 42.6%Kidney/Renal 5.6%Non-Hodgkin’sLymphoma 5.1%Liver 5%Bladder 4.9%Leukemia 4%Colorectal 4.8% Melanoma 4.9%Geographic Distribution by CountyALACHUA565MARION 288COLUMBIA107LAKE 86SUMTER82LEON79DUVAL76CLAY61BRADFORD47ST. JOHNS38ORANGE37ESCAMBIA31GILCHRIST31FLAGLER28ST. LUCIE27BAY26DIXIE23OKALOOSA21INDIAN RIVER19PALM WALTONMANATEEOSCEOLASANTA 1OUT OF STATE146OVERALL TOTALS 2732Shands at the University of Florida is rankedNo. 35 for cancer in the2011 U.S. News & WorldReport Rankings and isamong the elite, top 4 percent of all cancer hospitalsnationwide
2010 Primary Site TablePRIMARY SITETOTALPERCENTALL SITESORAL CAVITY2731157100.00%5.75%2251144DIGESTIVE SYSTEM49117.98%RESPIRATORY SYSTEM266BLOOD & BONE FT 253156BREASTFEMALE GENITAL2261588.28%5.79%191142351620224158MALE GENITAL1375.02%105321370URINARY SYSTEM28310.36%2305320875BRAIN & PHATIC SYSTEM1525.57%91618666UNKNOWN ACHCOLONRECTUMANUS/ANAL HUSOTHERLEUKEMIAMULTIPLE MYELOMAOTHERMELANOMAOTHERCERVIX UTERICORPUS EY/RENALOTHERBRAIN (BENIGN)BRAIN (MALIGNANT)OTHERTHYROIDOTHERHODGKIN’S 2711000234933417723471254A Analytic cases diagnosed and/or receiving all or part of the initial course of therapy at the UF Shands Cancer CenterN/A Non-analytic cases diagnosed and/or receiving all of the first course of therapy elsewhere; cases diagnosed at autopsy.Number of cases excluded 1. This report includes CA in-situ cervix cases, squamous and basal cell skin cases, and intraepithelial neoplasia cases.
Shands at UF Cancer Committee Membership 2010-11Robert Allan, MDMarcia Hodge, CTRMark Scarborough, MDSuzanne Bird, RD, LD/NFood and Nutrition ServicesRobert W. Hurley, MD, PhDAssociate Professor of AnesthesiologyMichele Scavone-StoneShirley Bloodworth, RN, BSN, MNFrederic Kaye, MDColeen Booker, RN, BSNJudith Lightsey, MDPatient and Family Resources/Patient ServicesLindy BrounleyMerry-Jennifer Markham, MDAndrew Smithson, MBAByron P. Croker, MD, PhDKevin McDonald, PTLee Starling, RHITKaren Daily, DOLinda S. Morgan, MDBruce Stechmiller, MDAssociate Professor of PathologyOncology Data CenterPatient AdvocateAssociate Professor of Hematology OncologyNurse Navigator, GI Oncology CenterAssociate Professor of Radiation OncologyAssociate Professor of OrthopedicsClinical Administration, ACU Adult Hematology Oncology and Shands Infusion CenterGale Smith, LCSWAssociate Professior of Hematology Oncology Associate VP Operations, Shands HealthcareCommunications Director, Cancer CenterAssociate Professor of PathologyRehabilitative ServicesAssistant Professor of Hematology OncologyHealth Information and Record ManagementAssociate Professor of Hematology OncologyJennifer M. Duff, MDProfessor of Obstetrics and Gynecology, Oncology Data Center Medical DirectorErin McQ. Dunbar, MDAssociate professor of RadiologyThomas George, MDMedical Director, Shands Cancer Hospital;Director, Cancer Center; Chair, RadiationOncologyAnne M. Tallent, CTRDeidra Pereira, PhDAssociate Professor of ProsthodonticsFellow, Hematology OncologyAssociate Professor of Neuro-OncologyAssociate Professor of Hematology OncologyScott Gilbert, MDAssociate Professor of UrologyJon Graham, PhDDeputy Director Clinical Admin, Cancer CtrSuzanne GreerKati Harlan, RN, MSN, LRHMFellow, Hematology OncologyPaul Okunieff, MDProfessor Emeritus of SurgeryAssociate Professor of Clinical and HealthPsychologyNina Powell, LCSWAndrew RagsdaleShands Quality ManagementSteven Hochwald, MDPatricia Moser, MDPatient and Family Resources/Patient ServicesAmerican Cancer SocietyMarketing/PR, Shands HealthcareAssociate Professor of Surgery, Cancer Committee Chair, Cancer Liaison PhysicianSukanthini Subbiah, MDSteve RitzClinical Administration,Radiation OncologyJames L. Talbert, MDOncology Data CenterGlenn E. Turner, DDSHelen Welsh, BSN, RNNursing, Shands HealthcareLaura Wiggins, PharmDPharmacy ServicesJohn R. Wingard, MDDirector, Bone Marrow Transplant Program;Deputy Director for Research, Cancer CenterFong Wong, DDSAssociate Professor of ProsthodonticsShands at UF Oncology Data CenterThe Oncology Data Center is an essential part of the hospital cancer program, functioning within the guidelines of the American College of Surgeons Commission on Cancer approvals program. The Oncology Data Center collects data on all cancer casesdiagnosed and/or treated at Shands at the University of Florida in Gainesville. In addition to maintaining the hospital’s database,the Oncology Data Center participates in several external oncology-related activities including the National Cancer Database,the American Cancer Society Facility Information Profile System, the Florida Cancer Data System and the Florida Associationof Pediatric Tumor Programs.Requests for data are welcomed and should be directed to: Shands at UF Oncology Data Center, PO Box 100342, Gainesville, FL32610-0342, (352) 265-0740, or emailed to Anne Tallent at tallea@shands.ufl.edu.PO Box 103633, Gainesville FL 32610Tel: (352) 273-8010 Online: cancer.ufl.edu
Chair, Shands at UF Cancer Committee Cancer Care Summary: 2010 Data Shands at the University of Florida Oncology Data Center has analyzed data for all patients with reportable disease first seen at UF Shands Cancer Center between Jan. 1, 2010 and Dec. 31, 2010. During that time, 2,731 new cases were diagnosed and/or treated here
